Filing
3rd Quarter - Report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 20, 2025
Expenses
$290,000.00
What this organization spent lobbying with its own staff.
Reported using A: the three
LDA methods count different costs, so an expenses figure is
not comparable across filers that used different ones.
Client based in
District of Columbia
Lobbyists on this filing
1
-
SHARA SIEGEL New on this filingPreviously held: Food and Drug Administration, Public Health Advisor (March 2024-June 2025)
Government bodies contacted
2
Lobbying activity
2
Oversight of, and reimbursement for, long-term care pharmacies, particularly PBM reform legislation and the impact of policy-driven changes in drug prices.
Oversight of, and reimbursement for, long-term care pharmacies, particularly PBM reform legislation and the impact of policy-driven changes in drug prices.